Last updated on October 2018

Safety and Efficacy of Vilazodone in Pediatric Patients With Major Depressive Disorder (VLZ-MD-22)


Brief description of study

The purpose of this study is to evaluate the efficacy, safety, and tolerability of vilazodone compared with placebo in pediatric outpatients (7-17 years of age) with major depressive disorder.

Clinical Study Identifier: NCT02372799

Contact Investigators or Research Sites near you

Start Over

Clinical Trial Registries Team

Harmonex Neuroscience Research
Dothan, AL United States
6.93miles

Recruitment Status: Closed


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.